LISATA THERAPEUTICS, INC. — Director's Dealing 2012

Jul 3, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2012-06-29

Reporting Person: Preti Robert A (See Remarks)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-06-29	Common stock, $0.001 par value	A	7652	$0.49	Acquired	1819709	Direct

Footnotes

F1: On March 14, 2012, the Compensation Committee of the Issuer's Board of Directors approved an arrangement whereby the Reporting Person shall receive, at his option on quarterly basis, the amount of his net salary increase effective January 19, 2012 pursuant to his January 2011 employment agreement, through the issuance to him by the Issuer of shares of the Issuer's common stock at the then-market price, under and subject to the terms and conditions of the Issuer's 2009 Equity Compensation Plan.